SK286027B6 - Farmaceutický prípravok bez hnacieho plynu, spôsob jeho výroby a jeho použitie - Google Patents

Farmaceutický prípravok bez hnacieho plynu, spôsob jeho výroby a jeho použitie Download PDF

Info

Publication number
SK286027B6
SK286027B6 SK527-2003A SK5272003A SK286027B6 SK 286027 B6 SK286027 B6 SK 286027B6 SK 5272003 A SK5272003 A SK 5272003A SK 286027 B6 SK286027 B6 SK 286027B6
Authority
SK
Slovakia
Prior art keywords
tiotropium
water
acid
pharmacologically acceptable
solvent
Prior art date
Application number
SK527-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK5272003A3 (en
Inventor
Barbara Niklaus-Humke
Christel Schmelzer
Petra Barth
Karin Drechsel
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SK5272003A3 publication Critical patent/SK5272003A3/sk
Publication of SK286027B6 publication Critical patent/SK286027B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK527-2003A 2000-10-31 2001-10-24 Farmaceutický prípravok bez hnacieho plynu, spôsob jeho výroby a jeho použitie SK286027B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054036 2000-10-31
PCT/EP2001/012292 WO2002036104A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (2)

Publication Number Publication Date
SK5272003A3 SK5272003A3 (en) 2003-10-07
SK286027B6 true SK286027B6 (sk) 2008-01-07

Family

ID=7661723

Family Applications (1)

Application Number Title Priority Date Filing Date
SK527-2003A SK286027B6 (sk) 2000-10-31 2001-10-24 Farmaceutický prípravok bez hnacieho plynu, spôsob jeho výroby a jeho použitie

Country Status (39)

Country Link
EP (2) EP1837021A3 (ja)
JP (1) JP4344135B2 (ja)
KR (1) KR100853107B1 (ja)
CN (2) CN101292964A (ja)
AR (1) AR038764A1 (ja)
AT (1) ATE373473T1 (ja)
AU (2) AU2002221738B2 (ja)
BG (1) BG66315B1 (ja)
BR (1) BRPI0115076B8 (ja)
CA (1) CA2426074C (ja)
CY (1) CY1107825T1 (ja)
CZ (1) CZ300794B6 (ja)
DE (2) DE50113037D1 (ja)
DK (1) DK1333819T3 (ja)
EA (1) EA007604B1 (ja)
EC (1) ECSP034541A (ja)
EE (1) EE05314B1 (ja)
ES (1) ES2294045T3 (ja)
HK (1) HK1060524A1 (ja)
HR (1) HRP20030338B1 (ja)
HU (1) HU229411B1 (ja)
IL (2) IL155538A0 (ja)
ME (1) ME00244B (ja)
MX (1) MXPA03003742A (ja)
MY (1) MY138940A (ja)
NO (1) NO332519B1 (ja)
NZ (1) NZ526023A (ja)
PE (1) PE20030092A1 (ja)
PL (1) PL203316B1 (ja)
PT (1) PT1333819E (ja)
RS (1) RS50859B (ja)
SA (1) SA01220482B1 (ja)
SI (1) SI1333819T1 (ja)
SK (1) SK286027B6 (ja)
TW (1) TWI293885B (ja)
UA (1) UA78690C2 (ja)
UY (1) UY26989A1 (ja)
WO (1) WO2002036104A2 (ja)
ZA (1) ZA200302922B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
CN1292748C (zh) * 2003-03-05 2007-01-03 南昌弘益科技有限公司 噻托溴铵吸入粉雾剂及其制备工艺
WO2005042528A1 (de) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Neue tiotropiumsalze, verfahren zu deren herstellung sowie diese enthaltende arzneimittelformulierungen
JP5165244B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
NZ563596A (en) 2005-05-02 2011-01-28 Boehringer Ingelheim Int Crystalline form of tiotropium bromide anhydrate
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
CN104306361A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含噻托溴铵的吸入性溶液
CN111374963A (zh) * 2018-12-31 2020-07-07 天津药业研究院有限公司 一种用于吸入的噻托铵溶液剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
EA200300482A1 (ru) 2003-12-25
MXPA03003742A (es) 2004-10-15
ECSP034541A (es) 2003-05-26
JP4344135B2 (ja) 2009-10-14
BG107727A (bg) 2004-11-30
NZ526023A (en) 2005-05-27
EE200300203A (et) 2003-10-15
AU2002221738B2 (en) 2007-01-11
NO20031911L (no) 2003-04-29
EP1333819A2 (de) 2003-08-13
MY138940A (en) 2009-08-28
TWI293885B (en) 2008-03-01
IL155538A0 (en) 2003-11-23
UY26989A1 (es) 2002-06-20
HUP0301378A3 (en) 2005-12-28
PT1333819E (pt) 2007-10-29
CN101292964A (zh) 2008-10-29
WO2002036104A2 (de) 2002-05-10
DE10152521A1 (de) 2002-07-11
CZ20031486A3 (cs) 2003-08-13
PL360405A1 (en) 2004-09-06
MEP40408A (en) 2011-02-10
AR038764A1 (es) 2005-01-26
ME00244B (me) 2011-05-10
AU2173802A (en) 2002-05-15
SI1333819T1 (sl) 2007-12-31
BRPI0115076B8 (pt) 2021-05-25
SK5272003A3 (en) 2003-10-07
BR0115076A (pt) 2003-07-29
CA2426074C (en) 2008-12-23
DK1333819T3 (da) 2007-12-03
CA2426074A1 (en) 2002-05-10
ES2294045T3 (es) 2008-04-01
HU229411B1 (en) 2013-12-30
DE50113037D1 (de) 2007-10-31
YU33003A (sh) 2006-05-25
CN100396285C (zh) 2008-06-25
PL203316B1 (pl) 2009-09-30
RS50859B (sr) 2010-08-31
IL155538A (en) 2008-11-26
HUP0301378A2 (hu) 2003-10-28
EP1333819B1 (de) 2007-09-19
CY1107825T1 (el) 2013-06-19
EA007604B1 (ru) 2006-12-29
CZ300794B6 (cs) 2009-08-12
BRPI0115076B1 (pt) 2016-07-26
HRP20030338B1 (en) 2011-09-30
JP2004512357A (ja) 2004-04-22
KR100853107B1 (ko) 2008-08-21
HK1060524A1 (en) 2004-08-13
EP1837021A3 (de) 2008-03-19
ATE373473T1 (de) 2007-10-15
NO332519B1 (no) 2012-10-08
EP1837021A2 (de) 2007-09-26
HRP20030338A2 (en) 2005-04-30
SA01220482B1 (ar) 2007-07-31
KR20030060926A (ko) 2003-07-16
CN1473038A (zh) 2004-02-04
NO20031911D0 (no) 2003-04-29
UA78690C2 (uk) 2007-04-25
EE05314B1 (et) 2010-08-16
BG66315B1 (bg) 2013-04-30
ZA200302922B (en) 2004-04-22
PE20030092A1 (es) 2003-03-24
WO2002036104A3 (de) 2002-08-01

Similar Documents

Publication Publication Date Title
US20020111363A1 (en) Inhalable formulation of a solution containing a tiotropium salt
SK286939B6 (sk) Inhalačný roztok bez hnacieho plynu, ktorý obsahuje jednu alebo viacero solí tiotrópia v kombinácii s jednou alebo viacerými soľami salmeterolu, a jeho použitie
US20040019073A1 (en) Aerosol formulation for inhalation containing a tiotropium salt
IL174496A (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20090317337A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
AU2003298473B2 (en) Aerosol formulation for inhalation containing an anticholinergic agent
CA2575385A1 (en) Aerosol formulation for inhalation, containing an anticholinergenic agent
CA2629082A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
CA2629074A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
CA2629073A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
CA2473815C (en) Aerosol formulation for inhalation containing a tiotropium salt
SK286027B6 (sk) Farmaceutický prípravok bez hnacieho plynu, spôsob jeho výroby a jeho použitie
SK288031B6 (sk) Propellant-free liquid inhalation formulation
NZ536282A (en) Aerosol formulation for inhalation comprising a tiotropium salt

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20211024